Skip to main content
logo
Ajanta Pharma Limited (NSE:AJANTPHARM)
India flag India · Delayed Price · Currency is INR
2,703.10
+4.80 (0.18%)
Jan 28, 2026, 1:40 PM IST

Ajanta Pharma Revenue

Ajanta Pharma had revenue of 13.54B INR in the quarter ending September 30, 2025, with 14.08% growth. This brings the company's revenue in the last twelve months to 49.73B, up 10.74% year-over-year. In the fiscal year ending March 31, 2025, Ajanta Pharma had annual revenue of 46.48B with 10.44% growth.

Revenue (ttm)
49.73B
Revenue Growth
+10.74%
P/S Ratio
6.78
Revenue / Employee
5.17M
Employees
9,628
Market Cap
336.98B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202546.48B4.39B10.44%
Mar 31, 202442.09B4.66B12.45%
Mar 31, 202337.43B4.02B12.02%
Mar 31, 202233.41B4.51B15.62%
Mar 31, 202128.90B3.02B11.66%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Aurobindo Pharma325.14B
Glenmark Pharmaceuticals159.97B
Alkem Laboratories138.90B
Ipca Laboratories93.59B
Piramal Pharma89.36B
Emcure Pharmaceuticals84.49B
Alembic Pharmaceuticals70.83B
Laurus Labs67.22B
Revenue Rankings

Ajanta Pharma News

More News